OrganiGram Holdings Inc Stock News

TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram Global”), the cannabis leader in Canada by market share, is pleased to announce its inaugural virtual investor event, the OG Investor Session, taking place on April 10, 2025, at 4pm EST. This online event offers investors a front-row seat to Organigram Global's next chapter. Attendees will g...

TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the "Company" or "Organigram"), Canada's #1 cannabis company by market share, is pleased to announce the acquisition of 100% of the issued and outstanding shares of Collective Project Limited (“CPL”) for upfront consideration of approximately C$6.2 million, potential milestone payments and potential earnout payments tot...

TORONTO--(BUSINESS WIRE)--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, is proud to announce its official rebrand to Organigram Global Inc. (“Organigram Global”), a move that demonstrates the Company's evolution from an East Coast medical cannabis company into a burgeoning global cannabis leader. Having achieved the ...

TORONTO--(BUSINESS WIRE)--Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI) (NASDAQ: OGI) announced today the results of voting at its annual general and special meeting of shareholders (the “Shareholders”) held virtually on March 24, 2025 (the “Meeting”). Shareholder Approval of the Name Change and Articles of Amendment At the Meeting, a special resolution approving an amendm...

TORONTO--(BUSINESS WIRE)--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, announced today that on February 28, 2025, the Company closed the third and last of three tranches (the “Third Tranche”) of the previously announced C$124,559,674 follow-on strategic equity investment (the “Investment”) by BT DE Investments Inc. ...

Organigram reported improved financial results for Q1-2025. OGI expects revenue to increase for Q2 as well as cash positions. OGI:CA sees growth in its international cannabis sales and Canadian sales.

Organigram's stock has declined significantly, but my bullish outlook remains due to strong fundamentals, strategic investments, and potential acquisition by British American Tobacco. The company reported a 17% revenue growth in Q1 FY24, driven by international expansion and the Motif Labs acquisition, despite missing expectations. Organigram's balance sheet is robust with C$46.8 million in cas...

Organigram Holdings Inc. (NASDAQ:OGI ) Q1 2025 Earnings Conference Call February 11, 2025 8:00 AM ET Company Participants Max Schwartz - Director of IR Beena Goldenberg - CEO Greg Guyatt - CFO Conference Call Participants Aaron Grey - Alliance Global Partners Yewon Kang - Canaccord Genuity Operator Good morning. My name is Krista, and I will be your conference operator today.